Zhang T, Chen L, Zhu H, Wong G
BMC Bioinformatics. 2025; 26(1):50.
PMID: 39934678
PMC: 11817350.
DOI: 10.1186/s12859-025-06068-6.
Wu X, Zhang L, Tong X, Wang Y, Zhang Z, Kong X
Brief Bioinform. 2024; 26(1).
PMID: 39592153
PMC: 11596087.
DOI: 10.1093/bib/bbae616.
Bi Y, Li F, Wang C, Pan T, Davidovich C, Webb G
Nucleic Acids Res. 2024; 52(19):11455-11465.
PMID: 39271121
PMC: 11514461.
DOI: 10.1093/nar/gkae782.
Uthayopas K, de Sa A, Alavi A, Pires D, Ascher D
Comput Struct Biotechnol J. 2024; 23:3030-3039.
PMID: 39175797
PMC: 11340604.
DOI: 10.1016/j.csbj.2024.06.030.
Miyano T, Mikkaichi T, Nakamura K, Yoshigae Y, Abernathy K, Ogura Y
Int J Mol Sci. 2024; 25(8).
PMID: 38673876
PMC: 11050142.
DOI: 10.3390/ijms25084291.
Role of kidney function on Nrf2 mRNA levels in type 2 diabetes.
Spoto B, Politi C, Postorino M, Parlongo R, Testa A, Tripepi G
BMJ Open Diabetes Res Care. 2024; 12(2).
PMID: 38575156
PMC: 11002371.
DOI: 10.1136/bmjdrc-2023-003929.
Gene dosage compensation: Origins, criteria to identify compensated genes, and mechanisms including sensor loops as an emerging systems-level property in cancer.
Bravo-Estupinan D, Aguilar-Guerrero K, Quiros S, Acon M, Marin-Muller C, Ibanez-Hernandez M
Cancer Med. 2023; 12(24):22130-22155.
PMID: 37987212
PMC: 10757140.
DOI: 10.1002/cam4.6719.
Circ_0000419 acts as a tumor suppressor in gastric cancer development via regulating miR-300/RGMB axis.
Lu J, Zhou Y, Chen Z, Jiang H, Li J, Dou G
Int J Clin Oncol. 2023; 28(11):1475-1485.
PMID: 37470948
DOI: 10.1007/s10147-023-02379-x.
Determinants of Functional MicroRNA Targeting.
Hwang H, Chang H, Baek D
Mol Cells. 2023; 46(1):21-32.
PMID: 36697234
PMC: 9880601.
DOI: 10.14348/molcells.2023.2157.
Non-canonical miRNA-RNA base-pairing impedes tumor suppressor activity of miR-16.
Quemener A, Bachelot L, Aubry M, Avner S, Leclerc D, Salbert G
Life Sci Alliance. 2022; 5(12).
PMID: 36202613
PMC: 9553902.
DOI: 10.26508/lsa.202201643.
mintRULS: Prediction of miRNA-mRNA Target Site Interactions Using Regularized Least Square Method.
Shakyawar S, Southekal S, Guda C
Genes (Basel). 2022; 13(9).
PMID: 36140696
PMC: 9498445.
DOI: 10.3390/genes13091528.
MicroRNA-570 targets the HSP chaperone network, increases proteotoxic stress and inhibits mammary tumor cell migration.
Okusha Y, Guerrero-Gimenez M, Lang B, Borges T, Stevenson M, Truman A
Sci Rep. 2022; 12(1):15582.
PMID: 36114410
PMC: 9481609.
DOI: 10.1038/s41598-022-19533-6.
miRNA Regulatory Networks Associated with Peripheral Vascular Diseases.
Zalewski D, Ruszel K, Stepniewski A, Galkowski D, Feldo M, Kocki J
J Clin Med. 2022; 11(12).
PMID: 35743538
PMC: 9224609.
DOI: 10.3390/jcm11123470.
hnRNPC induces isoform shifts in miR-21-5p leading to cancer development.
Park S, Yang H, Seo J, Nam J, Nam S
Exp Mol Med. 2022; 54(6):812-824.
PMID: 35729324
PMC: 9256715.
DOI: 10.1038/s12276-022-00792-2.
Exosome Carrier Effects; Resistance to Digestion in Phagolysosomes May Assist Transfers to Targeted Cells; II Transfers of miRNAs Are Better Analyzed via Systems Approach as They Do Not Fit Conventional Reductionist Stoichiometric Concepts.
Askenase P
Int J Mol Sci. 2022; 23(11).
PMID: 35682875
PMC: 9181154.
DOI: 10.3390/ijms23116192.
Circular RNA circASPM promotes the progression of glioblastoma by acting as a competing endogenous RNA to regulate miR-130b-3p/E2F1 axis.
Hou D, Wang Z, Li H, Liu J, Liu Y, Jiang Y
J Cancer. 2022; 13(5):1664-1678.
PMID: 35371308
PMC: 8965134.
DOI: 10.7150/jca.57691.
Application of OpenArray RT-qPCR for identification of microRNA expression signatures of lower extremity artery disease.
Zalewski D, Ruszel K, Stepniewski A, Galkowski D, Feldo M, Kocki J
J Appl Genet. 2022; 63(3):497-512.
PMID: 35366714
DOI: 10.1007/s13353-022-00692-1.
Relationships between Indicators of Lower Extremity Artery Disease and miRNA Expression in Peripheral Blood Mononuclear Cells.
Zalewski D, Ruszel K, Stepniewski A, Galkowski D, Feldo M, Kocki J
J Clin Med. 2022; 11(6).
PMID: 35329950
PMC: 8948757.
DOI: 10.3390/jcm11061619.
Multistability in Macrophage Activation Pathways and Metabolic Implications.
Geiss C, Salas E, Guevara-Coto J, Regnier-Vigouroux A, Mora-Rodriguez R
Cells. 2022; 11(3).
PMID: 35159214
PMC: 8834178.
DOI: 10.3390/cells11030404.
dosage compensation is mediated by miRNA-transcription factor interactions in aneuploid cancer.
Acon M, Geiss C, Torres-Calvo J, Bravo-Estupinan D, Oviedo G, Arias-Arias J
iScience. 2021; 24(12):103407.
PMID: 34877484
PMC: 8627999.
DOI: 10.1016/j.isci.2021.103407.